Swiss Nordic Bio 2022

Swiss Nordic Bio in Zürich is a high-level partnering and investor event where Swiss and Nordic biotech startups, pharmaceutical companies and investors meet. Swiss Nordic Bio carries 15 years of tradition, previously Swiss Scandinavian Bio-Business Seminar, and is organised by the Nordic countries in cooperation with Swiss partners


When: 23 March 2022

Where: Zürich Airport, Radisson Blu Hotel


The conference has a broad focus within biotech and pharma (drug development, drug delivery, bio materials, medical device, diagnostics, contract manufacturing, CRO, etc.) and gathers small, early stage companies as well as global, commercial corporations.
The conference is open for biotech and pharma companies as well as investors within the life science industry. For other types of companies other conditions apply (e.g. participation fee for business services providers is 2 500 EUR), please contact the Swiss Nordic Bio organization at or +43 699 1235 1519.


Participation Fee
General Admission Private SME Company:EUR 800 standard price (EUR 400 subsidised fee).
At the moment SMEs from following countries are eligible for subsidised fee: Finland, Norway, Sweden and Switzerland.

General Admission Public (Listed) Company:
For public (listed) companies that have been invited via Vator Securities, please contact Christoffer Bengtsson at

Investor / Business Developer / Innovation Scout: Free of charge

Business Service Provider: EUR 2 500

Partnership / Sponsorship / Co-organiser: To learn more about the partnership & sponsorship opportunities, please contact

Learn more and register here.